Pl eE
oe aod: 2"o-;
ts Te
(alm cere
Laboratory Investigation Report
<< ZZ rs
| Fr Collection Date/Time : 26/Apr/2025 06:46PM
; : Dr.Vyom Aggarwal Reporting Date/Time : 26/Apr/2025 09:07PM
Clinical Biochemistry OT CT
SIN No:SB2106884
Renal Function Test (RFT) Profile , Without Urine
Calcium, Serum
Date 26/Apr/2025 Unit Bio Ref Interval
06:46PM
Calcium (Total) 9.77 mg/dL 8.8 - 10.8
Arsenazo III
Comment
Increased in Primary and Tertiary hyperparathyroidism, malignant disease with bone involvement, Polycythemia vera, pheochromocytoma and Sarcoidosis.
Advise: PTH testing. If normal or increased, then check urine Ca**/ Creatinine ratio to exclude Familial benign hypocalciuric hypercalcemia (FBHH)
Decreased in surgical or congenital hyperparathyroidism; Vitamin D deficiency, chronic renal failure; magnesium deficiency, prolonged anticonvulsant therapy, acute
pancreatitis, hyperphosphatemia, massive blood transfusion, leprosy, proximal and distal renal tubular disease, alcoholism and hepatic cirrhosis.
Advice: Albumin, Phosphate, Creatinine, Alkaline Phosphatase and PTH.
Sodium, Serum
Date 26/Apr/2025 Unit Bio Ref Interval
06:46PM
Sodium 133.5 mmol/L 136 - 146
ISE indirect
Potassium, Serum
Date 26/Apr/2025 Unit Bio Ref Interval
06:46PM
Potassium 4.0 mmol/L 3.5-5.1
ISE indirect
Chloride, Serum
Date 26/Apr/2025 Unit Bio Ref Interval
06:46PM
Chloride 98.1 mmol/L 101 - 109
ISE indirect
Test Performed at :1060 - Max Hospital Shalimar Bagh, Max Lab nz
Booking Centre :1060 - Max Hospital Shalimar Bagh, Max Lab,
The authenticity of the report can be verified by scanning the Q R Code on top of the iy
Â®)
MC-2262